LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Aktien・Cara Therapeutics Inc

Cara Therapeutics Inc

Geschlossen

Branche Gesundheitswesen

0.29 -6.45

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.29

Max

0.31

Schlüsselkennzahlen
By Trading Economics
Einkommen	-28M
Verkäufe	-1.9M 3M
EPS	-0.59
Gewinnspanne	-576.079
Angestellte	55
EBITDA	-29M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+212.5 upside

Dividenden
By Dow Jones
Nächstes Ergebnis	11. Nov. 2024

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-2.3M 46M
Vorheriger Eröffnungskurs	6.74
Vorheriger Schlusskurs	0.29

Nachrichtenstimmung

By Acuity

79%

21%

321 / 365 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

0.3145 / 0.36 Unterstützung & Widerstand

Cara Therapeutics Inc Chart

Ähnliche Nachrichten

6. Sept. 2024, 22:41 UTC

Market Talk

KinderCare and StandardAero File for IPOs -- Market Talk

6. Sept. 2024, 21:18 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

6. Sept. 2024, 21:05 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

6. Sept. 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

6. Sept. 2024, 20:39 UTC

Ergebnisse

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

6. Sept. 2024, 20:35 UTC

Top News

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

6. Sept. 2024, 20:34 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

6. Sept. 2024, 20:11 UTC

Top News

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

6. Sept. 2024, 19:51 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

6. Sept. 2024, 19:16 UTC

Market Talk

U.S. Natural Gas Futures Hold Gains -- Market Talk

6. Sept. 2024, 19:14 UTC

Market Talk

Oil Futures Extend Losses on Demand Concerns -- Market Talk

6. Sept. 2024, 19:01 UTC

Market Talk

Gold Slips on Prevailing Uncertainty -- Market Talk

6. Sept. 2024, 18:27 UTC

Top News

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

6. Sept. 2024, 18:25 UTC

Market Talk

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

6. Sept. 2024, 18:15 UTC

Top News

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- Update

6. Sept. 2024, 18:12 UTC

Top News

Nasdaq Falls 2.5%, Leads Losses After Mixed Jobs Report -- WSJ

6. Sept. 2024, 17:44 UTC

Market Talk

Labor Costs Represent Diminishing Risk To Canada CPI, CIBC's Shenfeld Says -- Market Talk

6. Sept. 2024, 17:30 UTC

Market Talk

U.S Oil Rig Count Unchanged at 483 -- Market Talk

6. Sept. 2024, 17:30 UTC

Top News

Boeing's Starliner Is Returning to Earth Without Its Crew -- WSJ

6. Sept. 2024, 17:27 UTC

Top News

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- WSJ

6. Sept. 2024, 17:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. Sept. 2024, 17:00 UTC

Market Talk

Mexican Inflation Seen Easing in August -- Market Talk

6. Sept. 2024, 16:36 UTC

Market Talk

Oil Futures Fall as U.S. Jobs Report Sinks In -- Market Talk

6. Sept. 2024, 16:35 UTC

Ergebnisse

Heiße Aktien

Stocks to Watch Friday: Broadcom, Nvidia, UiPath, Smith & Wesson -- WSJ

6. Sept. 2024, 16:33 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Stock Is on Pace for Longest Losing Streak Since 2008. An Acquisition Isn't Helping. -- Barrons.com

6. Sept. 2024, 16:20 UTC

Market Talk

Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

6. Sept. 2024, 16:20 UTC

Ergebnisse

Oracle Profit, Revenue Set to Rise in 1Q -- Earnings Preview

6. Sept. 2024, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

6. Sept. 2024, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. Sept. 2024, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Cara Therapeutics Inc Prognose

Kursziel

By TipRanks

212.5% Vorteil

12-Monats-Prognose

Durchschnitt 1 USD 212.5%

Hoch 1 USD

Tief 1 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cara Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Cara Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

0.3145 / 0.36Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

There are no events.

Stimmung

By Acuity

321 / 365 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

EBITDA

Betriebsergebnis

Über Cara Therapeutics Inc

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). The Company is developing a class of product candidates KORSUVA (CR845/difelikefalin), which is a KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. The Company is also conducting preclinical studies and clinical trials of CR845/difelikefalin-based product candidates.